United States Patent Application: 0080185112

ثبت نشده
چکیده

The present invention provides methods for the thermolysis of lignocellulosic materials, such as wood, cellulose, lignin, and lignocellulose. In specific embodiments, the methods comprise combining the lignocellulosic material with an ionic liquid and subjecting the mixture of the lignocellulosic material and the ionic media to pyrolytic conditions to form a recoverable product, such as a commodity chemical. Inventors: Argyropoulos; Dimitris; (Raleigh, NC) Correspondence Name and Address: ALSTON & BIRD LLP BANK OF AMERICA PLAZA, 101 SOUTH TRYON STREET, SUITE 4000 CHARLOTTE NC 28280-4000 US Assignee Name and Adress: North Carolina State University

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Heart Carcinoid Disease with Patent Foramen Ovale Treated by Mini Sternotomy

This case report was an attempt to present the importance of diagnostic echocardiography and closure of a patent foramen ovale in carcinoid heart disease. Herein, we present a case of a 48-year-old woman with a carcinoid metastasis presenting with tricuspid regurgitation, pulmonic stenosis, patent foramen ovale, and borderline left ventricular ejection fraction on an echocardiogram. Surgical in...

متن کامل

In the United States Patent and Trademark Office

IN THE UNITED STATES PATENT AND TRADEMARK OFFICE In re Application of: RICHARD H. STERN APPLICATION MADE SPECIAL Serial No.: 11/166,991 Examiner: HARRIS, CHANDA L. Filed: 27 June 2005 Art Unit: 3715 For: MENTAL THERAPY METHOD FOR CATHARSIS OF NEGATIVE FEELINGS AMENDMENT Paper No. 6 Commissioner for Patents P.O. Box 1450 Alexandria, VA 22313-1450 Sir: In response to the first Office action maile...

متن کامل

Determination of regulatory review period for purposes of patent extension; Therma Choice Uterine Ballon Therapy System. Food and Drug Administration, HHS. Notice.

The Food and Drug Administration (FDA) has determined the regulatory review period for Therma Choice5 Uterine Ballon Therapy System and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Commissioner of Patents and Trademarks, Department of Commerce, for the extension of a patent which claims tha...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2008